- Accueil >
- Publications >
- Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma
Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma
Auteurs
Marine Baron, Lisa Belin, Nathalie Cassoux, Christine Fardeau, Marion Blaizeau, Carole Soussain, Caroline Houillier, Khê Hoang-Xuan, Emmanuel Gyan, Marie-Laure Le Lez, Anne Lavaud, Pierre Soubeyran, Bahram Bodaghi, Myrto Costopoulos, Véronique Leblond, Valérie Touitou, Karim Maloum, Marie-Hélène Errera, Damien Roos-Weil, Magali Le Garff-Tavernier, Sylvain Choquet
Résumé
Baron et al report excellent responses to temozolomide in 21 patients (19 relapsed/refractory) with primary vitreoretinal lymphoma. Treatment is well tolerated, even in elderly patients.